Psychiatric and behavioral manifestations of vascular dementia
- PMID: 17483668
- DOI: 10.1111/j.1076-7460.2007.06038.x
Psychiatric and behavioral manifestations of vascular dementia
Abstract
Vascular dementia (VaD) is the second most common cause of dementia, accounting for about 20% of all cases. Psychiatric and behavioral problems are at least as common in VaD as in Alzheimer's disease but are very different qualitatively. Patients with VaD, and especially those with small vessel disease, typically manifest symptoms related to damage to the frontal-subcortical system of the brain, including loss of executive function (which is not generally detected with most conventional tests of cognitive function), loss of drive, and disinhibited behaviors. Patients with VaD also commonly develop treatable mood disorders, most commonly depression. Once the symptoms are recognized, the clinician is in an ideal position to manage them and to educate caregivers about their nature.
Similar articles
-
Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.Curr Alzheimer Res. 2012 Jul;9(6):759-71. doi: 10.2174/156720512801322582. Curr Alzheimer Res. 2012. PMID: 22715983
-
Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.J Alzheimers Dis. 2018;62(2):699-711. doi: 10.3233/JAD-170365. J Alzheimers Dis. 2018. PMID: 29480171
-
Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.Psychogeriatrics. 2013 Dec;13(4):199-205. doi: 10.1111/psyg.12012. Epub 2013 Oct 28. Psychogeriatrics. 2013. PMID: 24289460
-
The concept of vascular cognitive impairment.Front Neurol Neurosci. 2009;24:79-85. doi: 10.1159/000197886. Epub 2009 Jan 26. Front Neurol Neurosci. 2009. PMID: 19182465 Review.
-
Diagnosis and management of vascular cognitive impairment and dementia.J Neural Transm Suppl. 2002;(63):91-109. doi: 10.1007/978-3-7091-6137-1_6. J Neural Transm Suppl. 2002. PMID: 12597611 Review.
Cited by
-
L-3-n-Butylphthalide Activates Akt/mTOR Signaling, Inhibits Neuronal Apoptosis and Autophagy and Improves Cognitive Impairment in Mice with Repeated Cerebral Ischemia-Reperfusion Injury.Neurochem Res. 2017 Oct;42(10):2968-2981. doi: 10.1007/s11064-017-2328-3. Epub 2017 Jun 15. Neurochem Res. 2017. PMID: 28620824
-
Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.Neurodegener Dis Manag. 2011 Apr;1(2):141-156. doi: 10.2217/nmt.11.9. Neurodegener Dis Manag. 2011. PMID: 21927623 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical